Johnson & Johnson Institute EMEA Stroke Symposium brings together leaders to address neurovascular challenges through collaboration
Stroke remains the second leading cause of death around the world and a leading cause of serious long-term disability. Despite these devastating consequences, progress is being made thanks to advances in endovascular techniques that hold the promise of changing the trajectory of stroke for more patients. In an effort to share the latest research and practical experience, CERENOVUS and the Johnson & Johnson Institute in Hamburg, Germany welcomed more than 200 neurovascular leaders from across Europe, Middle East and Africa (EMEA) to the second Stroke Symposium.
The program was designed to create a forum for current and future leaders in neuro-intervention to address the current challenges and unmet needs in treating ischaemic stroke and haemorrhagic neurovascular disease.
“Through educational forums such as these, we create an opportunity to better understand current neurovascular challenges and discuss how we can overcome them together, with the shared aim of providing the best care for stroke patients,” said Mark Dickinson, Worldwide President, Cerenovus. “I thank the scientific committee, faculty and attendees for sharing their insights and expertise. We look forward to our continued partnership and collaboration.”
Interactive, Peer-to-Peer Learning
The educational content focused on the following key areas:
- On-going challenges in mechanical thrombectomy and ischaemic stroke.
- Emerging technologies and treatment options for aneurysms.
- Lifecycle management of arterio-venous malformations.
Throughout the program, the objective was to provide a forum for audience participation and interaction. Live voting and open dialogue were used to debate and challenge the latest research, clinical decision making and patient treatment options.
“We all have challenging situations where it is not clear which treatment strategy works best,” said Dr. David Ozretic, University Medical Center, Zagreb, Croatia. “This symposium is a perfect opportunity to discuss those situations, share experience and try to find the best possible treatment option for the patient.”
Partnering to Reduce the Health and Economic Burden of Stroke
Stroke is a major contributor to healthcare costs, especially when you consider not only treatment expenses, but loss of productivity. Given that the incidence of stroke is on the rise, improving outcomes and the efficiency of care is a priority for many healthcare systems. The Johnson & Johnson Institute is committed to collaborating with the neurovascular community to deliver innovative education and training that can address this challenge.
““We were privileged to have the participation of delegates from thirty-five countries around the world,” said Aidan Ryan, Professional Education Manager. “And we look forward to sustaining strong educational partnerships focused on changing the trajectory of stroke and helping more patients regain optimal health.”